EculizumabAllergic reaction, convulsions and sepsis: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1644卷 / 1期

关键词：

D O I：

10.1007/s40278-017-27891-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：119 / 119

相关论文

共 50 条

[21] InfliximabInfusion related reaction, sepsis and lack of efficacy: 4 case reports
Reactions Weekly, 2023, 1954 (1) : 251 - 251
[22] AntineoplasticsHypersensitivity reaction, Aspergillus infection and fatal sepsis: 3 case reports
Reactions Weekly, 2019, 1734 (1) : 53 - 53
[23] GENERAL CONVULSIONS AND RHABDOMYOLYSIS - CASE-REPORTS
OS, I
LYNGDAL, PT
ACTA NEUROLOGICA SCANDINAVICA, 1989, 79 (03): : 246 - 248
[24] RituximabThromboembolism, bacterial pneumonia and sepsis: 2 case reports
Reactions Weekly, 2022, 1922 (1) : 518 - 518
[25] RuxolitinibGranulocytopenia and G⁃bacterium sepsis: 2 case reports
Reactions Weekly, 2023, 1950 (1) : 352 - 352
[26] Cytarabine/idarubicinInfectious disease and sepsis: 2 case reports
Reactions Weekly, 2017, 1648 (1) : 107 - 107
[27] Gemcitabine/temozolomideAnaemia and neutropenic sepsis: 2 case reports
Reactions Weekly, 2019, 1756 (1) : 165 - 165
[28] AntineoplasticsFatal neutropenic sepsis and pancreatitis: 2 case reports
Reactions Weekly, 2017, 1644 (1) : 29 - 29
[29] Ustekinumab/vedolizumabAbdominal abscesses and sepsis: 2 case reports
Reactions Weekly, 2022, 1928 (1) : 353 - 353
[30] MethylprednisoloneUrinary tract infection and sepsis: 2 case reports
Reactions Weekly, 2022, 1902 (1) : 281 - 281

← 1 2 3 4 5 →